The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
55 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $59,889,833 in first-year total cost, median $817,198.
Most frequent study sections
- Clinical Trials Review Study Section[CLTR (JA)]18
- Clinical Trials Review Study Section[CLTR (MA)]15
- Clinical Trials Review Study Section[CLTR (OA)]12
- Special Emphasis Panel[ZHL1 CSR-G (O1)]4
- Special Emphasis Panel[ZHL1 CSR-D (F1)]2
Most frequent institutions
- DUKE UNIVERSITY5
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH4
- BRIGHAM AND WOMEN'S HOSPITAL3
- UNIVERSITY OF ALABAMA AT BIRMINGHAM3
- UNIVERSITY OF MINNESOTA3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | TRANSFORM-HF CCC1U01HL125511-01A1 | VELAZQUEZ, ERIC J | DUKE UNIVERSITY, NC | $1,636,550 | CLTR |
| 2017 | SPIRRIT-HFPEF - CCC1U01HL134679-01 | PETERSON, ERIC DAVID | DUKE UNIVERSITY, NC | $1,597,707 | CLTR |
| 2017 | Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterms - DCC1U01HL136306-01 | DAS, ABHIK | RESEARCH TRIANGLE INSTITUTE, NC | $1,526,549 | CLTR |
| 2017 | Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)1R01HL134905-01 | KAWUT, STEVEN M | UNIVERSITY OF PENNSYLVANIA, PA | $1,160,837 | CLTR |
| 2017 | VCSIP2: CCC - Lead Application2R01HL105447-06 | MCEVOY, CYNTHIA T | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $1,055,286 | CLTR |
| 2017 | TRANSFORM-HF DCC1U01HL125478-01A1 | ANSTROM, KEVIN JEISENSTEIN, ERIC LEO | DUKE UNIVERSITY, NC | $842,495 | CLTR |
| 2017 | Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis1U01HL133232-01A1 | CRINER, GERARD JDUNCAN, STEVEN RKASS, DANIEL JROSAS, IVAN O. | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $787,346 | CLTR |
| 2017 | Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial1U01HL133815-01A1 | RAGNI, MARGARET VICTORIA | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $705,213 | CLTR |
| 2017 | Darbepoetin Trial to Improve Red Cell Mass and Neurodevelopment in Preterms-CCC1U01HL136318-01 | OHLS, ROBIN K | UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, NM | $356,966 | CLTR |
| 2017 | SPIRRIT-HFPEF - DCC1U01HL134694-01 | ANSTROM, KEVIN J | DUKE UNIVERSITY, NC | $334,160 | CLTR |
| 2017 | VCSIP2: DCC2R01HL105460-06 | MORRIS, CYNTHIA D | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $280,908 | CLTR |
| 2017 | Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - DCC1R01HL134904-01 | ELLENBERG, SUSAN S | UNIVERSITY OF PENNSYLVANIA, PA | $217,274 | CLTR |
| 2016 | ORBEX: Primary Prevention of Asthma and Wheezing in Children-CCC Lead Application1U01HL130045-01 | MARTINEZ, FERNANDO D | UNIVERSITY OF ARIZONA, AZ | $3,517,227 | CLTR |
| 2016 | Myocardial Ischemia and Transfusion (MINT) - CCC1U01HL133817-01 | CARSON, JEFFREY LEE | RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL, NJ | $3,277,466 | ZHL1 |
| 2016 | Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Data Coordinating Center (ALPS FS - DCC)2R01HL098354-04 | JABLONSKI, KATHLEEN ANNTHOM, ELIZABETH ANN | GEORGE WASHINGTON UNIVERSITY, DC | $1,903,799 | CLTR |
| 2016 | Clinical Implementation of Clopidogrel Pharmacogenetics: The TAILOR-PCI Trial - CCC - Lead Application1U01HL128606-01A1 | FARKOUH, MICHAEL EPEREIRA, NAVEEN LUKE | MAYO CLINIC ROCHESTER, MN | $1,716,012 | CLTR |
| 2016 | The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care - CCC - Lead Application1U01HL131552-01 | EPSTEIN, LEONARD HWILFLEY, DENISE ELLA | STATE UNIVERSITY OF NEW YORK AT BUFFALO, NY | $1,536,088 | CLTR |
| 2016 | Hybrid Coronary Revascularization Trial- DCC1U01HL125506-01A1 | BAGIELLA, EMILIAMOSKOWITZ, ALAN J | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $1,441,785 | CLTR |
| 2016 | INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)1U01HL130163-01 | SOLOMON, SCOTT DAVIDVARDENY, ORLY | BRIGHAM AND WOMEN'S HOSPITAL, MA | $1,334,454 | ZHL1 |
| 2016 | The ACCESS Trial - CCC1U01HL133818-01 | AUFDERHEIDE, TOM PAULYANNOPOULOS, DEMETRIS | UNIVERSITY OF MINNESOTA, MN | $955,977 | CLTR |
| 2016 | ORBEX: Primary Prevention of Asthma and Wheezing in Children-DCC1U01HL130050-01 | MAUGER, DAVID T. | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | $855,811 | CLTR |
| 2016 | Myocardial Ischemia and Transfusion (MINT) - DCC1U01HL132853-01 | BROOKS, MARIA MORI | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $775,743 | ZHL1 |
| 2016 | Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED)-CCC1U01HL131755-01A1 | MCCORMACK, FRANCIS XAVIER | UNIVERSITY OF CINCINNATI, OH | $752,151 | CLTR |
| 2016 | Clinical Implementation of Clopidogrel Pharmacogenetics: The TAILOR-PCI Trial - DCC1U01HL128626-01A1 | BAILEY, KENT R | MAYO CLINIC ROCHESTER, MN | $642,214 | CLTR |
| 2016 | KidsDOTT-CCC1U01HL130048-01A1 | GOLDENBERG, NEIL A | JOHNS HOPKINS UNIVERSITY, MD | $497,372 | CLTR |
| 2016 | INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated heart failure (INVESTED)-Data Coordinating Center1U01HL130204-01 | KIM, KYUNGMANN | UNIVERSITY OF WISCONSIN-MADISON, WI | $381,728 | ZHL1 |
| 2016 | KidsDOTT-DCC1U01HL130219-01A1 | HIATT, WILLIAM READ | UNIVERSITY OF COLORADO DENVER, CO | $379,974 | CLTR |
| 2016 | Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED) - DCC1U01HL131529-01A1 | KRISCHER, JEFFREY P | UNIVERSITY OF SOUTH FLORIDA, FL | $301,440 | CLTR |
| 2016 | The ACCESS Trial - DCC1U01HL132852-01 | CONNETT, JOHN E | UNIVERSITY OF MINNESOTA, MN | $252,858 | CLTR |
| 2016 | Hybrid Coronary Revascularization Trial - CCC1U01HL125488-01A1 | PUSKAS, JOHN DANIELSTONE, GREGG W. | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $246,691 | CLTR |
| 2016 | Pulmonary Complications in a Birth Cohort after a Randomized Trial of Antenatal Corticosteroids: the ALPS Follow-Up Study - Clinical Coordinating Center (ALPS-FS: CCC)2R01HL098554-04 | GYAMFI-BANNERMAN, CYNTHIA | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $175,170 | CLTR |
| 2016 | THE EFFECTIVENESS OF FAMILY-BASED WEIGHT LOSS TREATMENT IMPLEMENTED IN PRIMARY CARE - DCC1U01HL131639-01 | SCHECHTMAN, KENNETH B. | WASHINGTON UNIVERSITY, MO | $133,698 | CLTR |
| 2015 | Physical Activity to Improve CV Health in Women: A Pragmatic Trial CCC-Lead1U01HL122280-01A1 | STEFANICK, MARCIA L. | STANFORD UNIVERSITY, CA | $1,604,051 | CLTR |
| 2015 | IMPACT OF TREATMENT OF MILD SLEEP-DISORDERED BREATHING ON CHILDREN'S HEALTH-CCC1U01HL125295-01A1 | MARCUS, CAROLE L | CHILDREN'S HOSP OF PHILADELPHIA, PA | $1,532,963 | CLTR |
| 2015 | ICOMPARE-CCC1U01HL125388-01A1 | ASCH, DAVID A | UNIVERSITY OF PENNSYLVANIA, PA | $1,518,991 | CLTR |
| 2015 | Hematopoietic Stem Cell Transplantation for Young Adults with Sickle Cell Disease - Clinical Coordinating Center1U01HL128566-01 | KRISHNAMURTI, LAKSHMANANWALTERS, MARK C | EMORY UNIVERSITY, GA | $1,469,202 | CLTR |
| 2015 | American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT)1U01HL122894-01A1 | GERNSHEIMER, TERRY B | UNIVERSITY OF WASHINGTON, WA | $1,246,011 | CLTR |
| 2015 | Impact of treatment of mild sleep-disordered breathing on children's health-DCC1U01HL125307-01A1 | REDLINE, SUSAN S.WANG, RUI | BRIGHAM AND WOMEN'S HOSPITAL, MA | $961,423 | CLTR |
| 2015 | iCOMPARE - DCC1U01HL126088-01A1 | TONASCIA, JAMES A | JOHNS HOPKINS UNIVERSITY, MD | $882,919 | CLTR |
| 2015 | Physical Activity to Improve CV Health in Older Women: A Pragmatic Trial -- DCC1U01HL122273-01A1 | KOOPERBERG, CHARLES LLACROIX, ANDREA Z. | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $855,999 | CLTR |
| 2015 | A prospective trial of oral azithromycin when added to inhaled tobramycin in CF1R01HL124053-01A1 | NICHOLS, DAVID PAUL | NATIONAL JEWISH HEALTH, CO | $817,198 | ZHL1 |
| 2015 | 1/5 Bipolar-Schizophrenia Network for Intermediate Phenotypes 2 (B-SNIP 2) - Resu2R01MH077851-05A1 | TAMMINGA, CAROL A | UT SOUTHWESTERN MEDICAL CENTER, TX | $802,307 | ZMH1 |
| 2015 | Vitamin D to Prevent Severe Asthma Exacerbations in High-Risk Children - CCC1U01HL119952-01A1 | CELEDON, JUAN CARLOS | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $790,437 | CLTR |
| 2015 | Effects of HIV antiretroviral therapy on pulmonary function in a randomized trial2R01HL096453-06A1 | KUNISAKI, KEN M. | UNIVERSITY OF MINNESOTA, MN | $679,523 | CLTR |
| 2015 | Trial to Assess Chelation Therapy 2 (TACT2) DCC1UG3AT009150-01 | ANSTROM, KEVIN JMARK, DANIEL B | DUKE UNIVERSITY, NC | $542,608 | ZHL1 |
| 2015 | Trial Using Epsilon Aminocaproic Acid Therapy in Thrombocytopenia - DCC1U01HL122272-01A1 | EMERSON, SCOTT S | UNIVERSITY OF WASHINGTON, WA | $453,893 | CLTR |
| 2015 | Trial to Assess Chelation Therapy 2- TACT2 CCC1UG3AT009149-01 | LAMAS, GERVASIO A | MOUNT SINAI MEDICAL CENTER (MIAMI BEACH), FL | $400,000 | ZHL1 |
| 2015 | Vitamin D to Prevent Severe Asthma Exacerbations in High-Risk Children: DCC1U01HL119963-01A1 | WISNIEWSKI, STEPHEN R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $382,192 | CLTR |
| 2015 | Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC1U01HL128568-01 | EAPEN, MARYMENDIZABAL, ADAM M. | MEDICAL COLLEGE OF WISCONSIN, WI | $357,656 | CLTR |
| 2014 | REPRIEVE - CCC - Lead Application1U01HL123336-01 | DOUGLAS, PAMELA SUSANGRINSPOON, STEVEN K. | MASSACHUSETTS GENERAL HOSPITAL, MA | $6,060,885 | ZHL1 |
| 2014 | Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating Center1U01HL120338-01A1 | TITA, ALAN THEVENET N. | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $2,447,779 | CLTR |
| 2014 | RANDOMIZED CONTROLLED TRIAL: VDAART CONTINUATION STUDY - DCC - LEAD2R01HL091528-06 | LITONJUA, AUGUSTO AWEISS, SCOTT T | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,067,659 | CLTR |
| 2014 | REPRIEVE - DCC1U01HL123339-01 | HOFFMANN, UDORIBAUDO, HEATHER JANE | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,359,105 | ZHL1 |
| 2014 | Chronic Hypertension and Pregnancy (CHAP): Data Coordinating Center1U01HL119242-01A1 | CUTTER, GARY R | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $626,518 | CLTR |
| 2014 | Randomized Controlled Trial: VDAART Continuation Study - CCC2R01HL091075-06 | STRUNK, ROBERT | WASHINGTON UNIVERSITY, MO | $451,565 | CLTR |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.